banner

BioTrinity 2019

BioTrinity, now in its 13th year, is Europe’s leading Biopartnering and Investment conference, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.

BioTrinity 2019 incorporates significant improvements including a move to etc.venues 155 Bishopsgate, a central London location. This new venue allows us to keep all activity on one floor which will focus the energy and facilitate interaction, thereby maximising visibility for our sponsors, exhibitors, BioLaunchPad® presenters and creating even more opportunities for networking and informal meetings.

 

The focus of the 2019 conference is to look at 'What’s new' in the industry, and we’ll be providing updates and insight on both technical and financial developments across a wide range of key therapeutics areas – have a look at the Draft Programme.

 

 

 

 

Event Details

Date:

Tuesday, April 30, 2019 - Wednesday, May 1, 2019

Location:

155 Bishopsgate is a large conference, event and exhibition venue located next to Liverpool St. Station in The City of London

etc.venues 155 Bishopsgate
London
EC2M 3YD

Price:

See overview on https://www.biotrinity.com/pricing

 

FLANDERS.BIO MEMBER BENEFIT: flanders.bio members receive a 10% reduction on the registration fee. Please contact us to obtain the reduction code.

Language:

English

Organiser(s):

2019-04-30 08:00:00 2019-05-01 17:30:00 Europe/Brussels BioTrinity 2019 155 Bishopsgate is a large conference, event and exhibition venue located next to Liverpool St. Station in The City of Londonetc.venues 155 BishopsgateLondonEC2M 3YD <p><img style="width: 231px; height: 144px;" src="/media/3630/obn_main_logo_bns_rgb_150ppi.png?width=231&amp;height=144" alt="" data-id="9492"></p>

More info?

For any further information about this event, please do not hesitate to get in touch with our Event Coordinator

Alternate Text

Lissa Van Hecke

Event Coordinator

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?